Home/ Stocks/ ARWR

Arrowhead Research Corporation

ARWR XNAS

$87.65 +1.82 (+2.12%) ▲ 15-min delayed

Open

$88.00

High

$88.67

Low

$86.48

Volume

948.2K

Market Cap

$12.12B

About Arrowhead Research Corporation

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 711 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2026	$75.25M	$-178,916,000	$-1.36
Q2 2026	$73.74M	$-137,572,000	$-0.93
Q1 2026	$264.03M	$28.24M	$0.22
FY 2025	$829.45M	$30.11M	$-0.01

Related Market News

No specific coverage for ARWR yet. Check out our latest market news or earnings calendar.

Get ARWR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Arrowhead Research Corporation.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.